DiscoverPharmaLex Talks20: Safety Reporting Requirements for Marketing in the EU
20: Safety Reporting Requirements for Marketing in the EU

20: Safety Reporting Requirements for Marketing in the EU

Update: 2023-07-06
Share

Description

For US-based companies seeking to market their product in the EU, it can be a struggle to navigate a different market, and, in particular, to manage requirements from a safety reporting perspective. The podcast explores the challenges faced managing not only the European pharmacovigilance legislation but also dealing with each EU Member State, which can implement these requirements in their own way at the national level.



Bios:



Monica Buchberger is senior director of pharmacovigilance at PharmaLex, drawing on her many years in industry in pharmacovigilance and regulatory roles, including quality assurance systems and serving as the EU QPPV for Abbott Laboratories.



Stephen Sun is a physician by training who heads up the US pharmacovigilance team for global PharmaLex and is also the service area head for benefit-risk management.
Comments 
00:00
00:00
1.0x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

20: Safety Reporting Requirements for Marketing in the EU

20: Safety Reporting Requirements for Marketing in the EU

PharmaLex Talks